Gregory S. Ahearn

TL;DR: In this article, the authors provide evidence-based treatment recommendations for physicians involved in the care of patients with pulmonary arterial hypertension (PAH), taking into consideration studies published prior to September 1, 2006, providing an update to the previously published guidelines.

TL;DR: This chapter will provide evidence based recommendations to assess the prognosis of patients with PAH and investigate the potential benefits and risks of different types of medical therapies.

TL;DR: GSNOR(-/-) mice have increased basal levels of SNOs in red blood cells and are hypotensive under anesthesia, indicating that SNOs regulate innate immune and vascular function, and are cleared actively to ameliorate nitrosative stress.

TL;DR: The findings indicate that NO bioactivity is depleted in banked blood, impairing the vasodilatory response to hypoxia, and they suggest that SNO-Hb repletion may improve transfusion efficacy.

TL;DR: Women are at increased risk for DVT and PE during pregnancy for several reasons, and women with a history of thrombotic complications during pregnancy have an increased prevalence of genetic mutations related to coagulation.